| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/07/2011 | US20110082091 Method for Preclinical Testing of Immunomodulatory Drugs |
| 04/07/2011 | US20110081383 Live attenuated leishmania vaccines |
| 04/07/2011 | US20110081377 Aerosolized genetic vaccines and methods of use |
| 04/07/2011 | US20110081376 Method for using inactivated japanese encephalitis virus particles as adjuvant |
| 04/07/2011 | US20110081375 Chimeric adenoviral vectors |
| 04/07/2011 | US20110081374 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 04/07/2011 | US20110081373 Attenuating mutations in the influenza a virus nep(=ns2) protein |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/07/2011 | US20110081370 Methods and Compositions for Modulating Immune Tolerance |
| 04/07/2011 | US20110081369 Immune modulation with death receptor-induced apoptosis |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081365 Compounds and compositions as tlr activity modulators |
| 04/07/2011 | US20110081364 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 04/07/2011 | US20110081358 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 04/07/2011 | US20110081356 Anti-cancer drug |
| 04/07/2011 | US20110081355 Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies |
| 04/07/2011 | US20110081351 Antihuman baff antibody |
| 04/07/2011 | US20110081349 Allergenic latex protein |
| 04/07/2011 | US20110081345 Single chain fc, methods of making and methods of treatment |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081343 Vaccines directed to langerhans cells |
| 04/07/2011 | US20110081341 Immunopotentiative composition |
| 04/07/2011 | US20110081340 Methods for treating disease using an anti-il-21 receptor antibody |
| 04/07/2011 | US20110081327 Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection |
| 04/07/2011 | US20110081321 Omentum as a source of stromal/stem cells and medical treatments using stromal/stem cells |
| 04/07/2011 | US20110081317 Enhancing Gene Transfer |
| 04/07/2011 | US20110081316 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | US20110081313 Mechanism of action of primary cell derived biologic |
| 04/07/2011 | US20110081292 Methods Of Treating Viral Hepatitis |
| 04/07/2011 | CA2779506A1 Methods of improving vaccine immunogenicity |
| 04/07/2011 | CA2776386A1 Piscine reovirus immunogenic compositions |
| 04/07/2011 | CA2776195A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | CA2774047A1 Method and system for accessing patient data |
| 04/07/2011 | CA2773330A1 Dosage regimen of an s1p receptor modulator |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305796A1 Process for producing cytotoxic lymphocytes |
| 04/06/2011 | EP2305793A1 Process for producing cytotoxic lymphocytes |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305663A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 04/06/2011 | EP2305660A1 New thiadiazole derivatives |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305308A1 Remedies for diseases to be applied to eye |
| 04/06/2011 | EP2305305A1 Agent for induction/maintenance of remission |
| 04/06/2011 | EP2305304A1 Immunopotentiating agent comprising ep1 agonist |
| 04/06/2011 | EP2305299A1 Chimeric alphavirus replicon particles |
| 04/06/2011 | EP2305292A1 S/o type transdermal immunizing agent |
| 04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
| 04/06/2011 | EP2305269A2 Immunemodulating oligosaccharides |
| 04/06/2011 | EP2305268A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe |
| 04/06/2011 | EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels |
| 04/06/2011 | EP2303850A1 Novel potassium channel blockers and uses thereof |
| 04/06/2011 | EP2303846A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 04/06/2011 | EP2303845A2 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors |
| 04/06/2011 | EP2303407A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells |
| 04/06/2011 | EP2303323A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 04/06/2011 | EP2303294A1 Probiotics to improve gut microbiota |
| 04/06/2011 | EP2303293A1 Methods of treating inflammatory colon diseases |
| 04/06/2011 | EP2303287A1 Antiallergic marine biopolymers |
| 04/06/2011 | EP2303261A1 Use of cyclolignans for the treatment of a hyperactive immune system |
| 04/06/2011 | EP2303251A1 New combination for use in the treatment of inflammatory disorders |
| 04/06/2011 | EP2303250A1 Paediatric compositions for treating1 multiple sclerosis |
| 04/06/2011 | EP2125788B1 Heterocyclic compounds, compositions comprising them and methods of their use |
| 04/06/2011 | EP1628968B1 4-imidazolin-2-one compounds |
| 04/06/2011 | EP1602660B1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 04/06/2011 | EP1529113B1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 04/06/2011 | EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 04/06/2011 | EP1411979B1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/06/2011 | CN1981869B Compound non-carrier antibacterial eye drops containing practofren and its production |
| 04/06/2011 | CN1930283B Leukocyte stimulation matrix |
| 04/06/2011 | CN1859909B Solid dispersions comprising tacrolimus |
| 04/06/2011 | CN1840177B Injection liquid of thymic peptide alpha 1 and preparation method thereof |
| 04/06/2011 | CN1812980B Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102007107A Novel aminomethyl benzene derivatives |
| 04/06/2011 | CN102006891A Continuous cell programming devices |
| 04/06/2011 | CN102002493A Application of small RNA-326 in preparation of medicament |
| 04/06/2011 | CN102002110A Preparation method of polysaccharides from sea cucumber |
| 04/06/2011 | CN102002106A Fusion protein MBP-NAP and preparation method and application thereof |
| 04/06/2011 | CN102002052A Ginkgolides K and compound thereof as well as preparation method and use thereof |
| 04/06/2011 | CN102002050A Bisbenzylisoquinoline derivative and preparation and application thereof |
| 04/06/2011 | CN102000329A Improved flagellin mucosa adjuvant from non-pathopoiesia bacteria source and preparation method thereof |
| 04/06/2011 | CN102000323A Application of SJ16 protein in preparing immunosuppressive drugs |
| 04/06/2011 | CN102000265A Traditional Chinese medical composition for strengthening immunity and application thereof |
| 04/06/2011 | CN102000258A Traditional Chinese medicinal preparation capable of resisting fatigue and increasing immunity |
| 04/06/2011 | CN102000242A Medicine for treating chronic disease associated malnutrition and application thereof |
| 04/06/2011 | CN102000238A Martianus dermestoides capsule and preparation method |
| 04/06/2011 | CN102000212A Method for preparing composite earthworm health-care product |
| 04/06/2011 | CN102000172A Oral liquid, granules and powder for preventing and treating chronic allergic rhinitis |
| 04/06/2011 | CN102000152A Preparation method for composite gingkgo health product |
| 04/06/2011 | CN102000135A Jingtianling traditional Chinese medicine preparation and preparation method |
| 04/06/2011 | CN102000118A Method for preparing external medicinal liquor from raw propolis |
| 04/06/2011 | CN102000113A Method for preparing nano donkey-hide gelatin granules with polymer as carrier |